side effect of glp-1 Managing Effects Receptor Agonists – Transformation Weight Control Q&A: Long-term success of GLP-1

Supplementary information Source data Source Data Fig

I just want you to know we're still waiting on big definitive results here, especially when we talk about Alzheimer's

Clinical studies indicate that patients can achieve a significant reduction in body weight, often between 10% to 15% of their initial weight, over approximately 68 weeks

After setbacks in internal oral GLP-1 development, Pfizer moved to strengthen its position through acquisition activity, including its move for Metsera and its next-generation obesity portfolio

Randomised controlled trial of bariatric surgery versus a community weight loss programme for the sustained treatment of idiopathic intracranial hypertension: the idiopathic intracranial hypertension weight trial (IIH: WT) protocol

While our meta-analysis demonstrated robust protective associations between GLP-1R activation and psychiatric conditions such as schizophrenia and anxiety disorders, sensitivity analyses revealed broader CIs that occasionally crossed the null